Ritalin and similar medicines that millions of children and teens take to curb hyperactivity and boost attention do not raise their risk of serious heart problems, the largest safety study of these drugs concludes.
Heart attacks, strokes and sudden death were very rare and no more common in children on the drugs than in kids not taking them, the federally funded study found. That was true even for children and young adults with a higher risk of heart problems — a group doctors have long worried about when prescribing these drugs.
“This study would suggest that their risk is remarkably low. And that’s good news,” said the study’s leader, Dr. William Cooper, a pediatrics and preventive medicine professor at Vanderbilt University.
“Parents should be very reassured,” said Dr. Laurel Leslie, a pediatrician at Tufts Medical Center in Boston who had no role in the study but served on a Food and Drug Administration advisory panel examining drugs for ADHD, or attention deficit-hyperactivity disorder.
The study was sponsored by the federal Agency for Healthcare Research and Quality and the FDA. Results were published online Tuesday by the New England Journal of Medicine. Results from similar studies of these medicines in adults are expected soon.
More than
Read More from the Article Source: Full Article
